Global Antacids Market is expected to reach US$ XX Mn by 2026 from US$ XX Mn in 2019, at a CAGR of 3.8% during the forecast period.
Global Antacids Market Overview:
Antacids are a form of medication that neutralises stomach acid. They include alkalizing ingredients like aluminium, calcium, magnesium, or sodium bicarbonate, which serve as bases to neutralise stomach acid.
Global Antacids Market Dynamics:
The rising prevalence of Gastroesophageal reflux Disorders and other digestive disorders are the primary factors driving the growth of the market.
The prevalence of GERD is rising worldwide. The World Gastroenterology Organization, states that GERD affects nearly 2.5 % to 6.7 % in Asia and nearly 13.9 % to 25.8 % in North America. Unhealthy diet patterns, a rising geriatric population, a sedentary lifestyle, and an increase in the incidence of digestive disorders are some other factors boosting the demand for the antacids market. Increasing awareness about gastrointestinal disorders, gastric ulcers and the prevalence of heartburn fuels the market growth.
The American College of Gastroenterology states that around 60 million Americans experience heartburn at least once a month, and it also states that, more than 15 million Americans will experience heartburn symptoms every day. Various awareness initiatives are being undertaken by the government to spread awareness regarding GERD. During the 19th Annual GERD Awareness Week in November 2018, the International Foundation for Gastrointestinal Disorders offered information and support on GERD. It also encourages people suffering from GERD to seek medical attention from their physician.
Apart from these driving factors, certain restraining factors may impact negatively on the market growth. The presence of alternative antacid treatments such as natural therapeutics is being used to eliminate side-effect caused by antibiotics, whose demand is increasing in Ayurveda may hamper the antacids market growth. Other alternative therapies such as acupuncture, melatonin, hypnotherapy, baking soda, and lifestyle improvements are also present which are expected to restrain the market growth. Along with this, side effects associated with antacids such as intoxication and hypophosphatemia are also responsible for hampering the market growth.
The report has profiled seventeen key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.
Global Antacids Market Segment Analysis:
The Global Antacids Market is segmented on the basis of Drug Type, Dosage Form and Distribution Channel.
Based on Drug Type, the Proton Pump Inhibitors segment is estimated to account for significant market share during the forecast period. The segment is expected to register a CAGR of 4.5% during forecast years. The ease of availability of these drugs aids the segment growth. PPIs stop the stomach from producing acid. They're the most effective medications for reducing acid content, and they're best for people who have heartburn on a regular basis.
They're usually the most successful Gastroesophageal Reflux Disease (GERD) therapy. Omeprazole (Prilosec), lansoprazole (Prevacid), esomeprazole (Nexium), dexlansoprazole (Dexilant), and omeprazole with sodium bicarbonate are some of the approved and currently available PPIs. On January 25 2019, a massive multi-centre clinical trial was conducted for evaluating the proton pump inhibitor omeprazole as a cough treatment in patients with idiopathic pulmonary fibrosis (IPF). Based on the results, the treatment appears to be feasible for use.
Based on Dosage Form, the Tablet segment held the dominant market share in 2019. The segment is expected to be the largest segment during the forecast period due to the availability of a variety of chewable tablets in various flavours in the market, which aid in patient adherence to medication and, as a result, are expected to contribute to the segment's development.
As compared to other dosage types, certain driving factors such as tablets provide patients with the exact amount of medication they need and are easy to store, contribute to the segment growth. Also, the launch of new products by major players is expected to be another key driver for the segment's growth.
Global Antacids Market
To know about the Research Methodology :- Request Free Sample Report
Global Antacids Market Regional Insights:
Global Antacids Market 1
North America is expected to dominate the global market during the forecast period.
The region is anticipated to account for the largest market share owing to the rising prevalence of Gastroesophageal reflux disorders. Approximately 20% of the population is affected by GERD, states the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Advances in technology, ongoing research activities for the production of new novel drugs and ease of availability are some prominent factors boosting the market growth in this region.
APAC region is expected to witness lucrative growth during the forecast period.
Due to high unmet health needs, availability of treatment options, rising disposable income, and rising awareness about the availability of these medications, Asia Pacific is expected to be the fastest-growing regional segment during the forecast period. Furthermore, the rising geriatric population also aids the market growth in APAC.
The report also helps in understanding Global Antacids Market dynamics, structure by analyzing the market segments and project the Global Antacids Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Antacids Market make the report investor’s guide.
Global Antacids Market, Key Development:
There is a new trend emerging in the antacid industry is a mouth-melting antacid. Until now, antacids were only available in tablet, liquid, or powder form; however, researchers have developed mouth-melting antacids that are made up of micro mouth-melting granules that melt easily in the mouth. The granules in antacids have an effervescent effect. Sun pharma's 'Pepmelt’ is a mouth-melting instant relief antacid that combines the effects of herbal constituents with modern mouth-melting technology.
FOR MORE INFO VISIT US: https://www.maximizemarketresearch.com/market-report/global-antacids-market/100180/
Global Antacids Market Scope: Inquire before buying
Global Antacids Market 2
Global Antacids Market, by Region
• North America
• South America
Global Antacids Market Key Players
• GlaxoSmithKline plc
• Bayer AG
• Boehringer Ingelheim International GmbH
• Dr. Reddy’s Laboratories Ltd.
• Reckitt Benckiser Group plc
• Sun Pharmaceuticals Ltd.
• Takeda Pharmaceutical Company Limited
• Pfizer Inc.
• Procter & Gamble
• Perrigo Company plc
• Johnson & Johnson Services, Inc.
• Salix Pharmaceuticals
• Mylan N.V.
• Aurobindo Pharma
For More Information Visit @: Maximize Market Research Company
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.